Logo do repositório
 
Publicação

Frenchay dysarthria assessment (FDA-2) in Parkinson’s disease: cross-cultural adaptation and psychometric properties of the european portuguese version

2016-10-17Artigo científico Acesso restrito
Ver registo simples
dc.contributor.authorCardoso, Rita
dc.contributor.authorGuimarães, Isabel
dc.contributor.authorSantos, Helena
dc.contributor.authorLoureiro, Rita
dc.contributor.authorDomingos, Josefa
dc.contributor.authorAbreu, Daisy
dc.contributor.authorGonçalves, Nilza
dc.contributor.authorPinto, Serge
dc.contributor.authorFerreira, Joaquim
dc.date.accessioned2022-04-01T12:22:16Z
dc.date.available2022-04-01T12:22:16Z
dc.date.issued2016-10-17
dc.description.abstractHypokinetic dysarthria is a common symptom in those with Parkinson’s disease (PD); there is currently no standardized or validated tool for assessing speech in this population. To translate into European Portuguese (EP) the FDA-2 and perform a cultural adaptation followed by an evaluation of its psychometric properties in PD in a sample of people with PD in different stages of disease progression. Translation, back-translation, experts’ analysis, pretest and final version test were performed. The EP version of the FDA-2 was administered to 80 people with PD (PwP) with dysarthria, feasibility and acceptability, reliability (internal consistency and inter-rater reliability) and validity (face and convergent) were measured. Overall, the EP-FDA-2 proved to be similar to the original demonstrating the same conceptual meanings, semantics, idiomatic and score equivalences. It has good feasibility (missing data\5 %), acceptability (ceiling and floor effects \15 %), a high reliability of the total score (0.94), an excellent inter-rater agreement for the total score (0.96) and moderate to large construct validity for 81 % of its items. It is well correlated with the gold standard for disease severity assessment in PD, the MDS-UPDRS. The EPFDA- 2 has shown the salient features of a valid tool that can be used by speech and language therapists in the assessment of dysarthria in PD in clinical practice as in the research field.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doiDOI 10.1007/s00415-016-8298-6pt_PT
dc.identifier.issn0340-5354
dc.identifier.urihttp://hdl.handle.net/10400.26/40003
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringerpt_PT
dc.subjectParkinson’s diseasept_PT
dc.subjectDysarthriapt_PT
dc.subjectScalept_PT
dc.subjectSpeechpt_PT
dc.subjectParkinsonismpt_PT
dc.titleFrenchay dysarthria assessment (FDA-2) in Parkinson’s disease: cross-cultural adaptation and psychometric properties of the european portuguese versionpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage31pt_PT
oaire.citation.issue264pt_PT
oaire.citation.startPage21pt_PT
oaire.citation.titleJournal of Neurologypt_PT
oaire.citation.volume2017pt_PT
person.familyNamecardoso
person.familyNameGuimarães
person.givenNamerita
person.givenNameIsabel
person.identifier548796
person.identifier.ciencia-idF014-BFD6-49C2
person.identifier.orcid0000-0002-4478-990X
person.identifier.orcid0000-0001-8524-8731
person.identifier.scopus-author-id24586862700
rcaap.rightsrestrictedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication0d976fcb-d1b8-478a-8163-250052500b7f
relation.isAuthorOfPublicationdc9a77a2-eecf-4d30-88fa-4200275eccf5
relation.isAuthorOfPublication.latestForDiscovery0d976fcb-d1b8-478a-8163-250052500b7f

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Cardoso2017_Article_FrenchayDysarthriaAssessmentFD.pdf
Tamanho:
754.6 KB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

ESSA - TF - Artigos em revistas científicas